Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
4.700
-0.180 (-3.69%)
At close: Dec 5, 2025, 4:00 PM EST
4.810
+0.110 (2.34%)
After-hours: Dec 5, 2025, 7:53 PM EST
Aldeyra Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 283 | 297 | 206 | 408 | 232 | 266 | |
| Market Cap Growth | 1.02% | 43.92% | -49.34% | 75.40% | -12.74% | 63.98% | |
| Enterprise Value | 223 | 240 | 79 | 260 | 132 | 210 | |
| Last Close Price | 4.70 | 4.99 | 3.51 | 6.96 | 4.00 | 6.86 | |
| PB Ratio | 5.74 | 4.18 | 1.72 | 2.70 | 1.13 | 4.47 | |
| P/TBV Ratio | 5.74 | 4.18 | 1.72 | 2.70 | 1.13 | 4.47 | |
| Debt / Equity Ratio | 0.32 | 0.22 | 0.13 | 0.11 | 0.08 | 0.26 | |
| Quick Ratio | 2.64 | 5.44 | 6.42 | 11.56 | 8.90 | 4.26 | |
| Current Ratio | 2.72 | 5.60 | 6.64 | 11.79 | 19.77 | 6.69 | |
| Return on Equity (ROE) | -64.31% | -58.54% | -27.73% | -34.77% | -43.56% | -69.81% | |
| Return on Assets (ROA) | -28.94% | -29.71% | -16.23% | -18.91% | -22.20% | -27.28% | |
| Return on Capital (ROIC) | -34.12% | -33.89% | -17.68% | -20.16% | -23.71% | -31.48% | |
| Return on Capital Employed (ROCE) | -91.60% | -69.90% | -33.90% | -37.80% | -25.40% | -48.90% | |
| Earnings Yield | -15.28% | -18.80% | -18.18% | -15.22% | -24.86% | -14.10% | |
| FCF Yield | -14.18% | -14.54% | -14.69% | -13.90% | -18.32% | -14.08% | |
| Buyback Yield / Dilution | -0.88% | -0.92% | -0.92% | -8.08% | -59.11% | -25.28% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.